KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea · Delayed Price · Currency is KRW 8,380.00
-550.00 (-6.16%)
At close: Jun 19, 2026
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 91.4 billion as of June 18, 2026. Its market cap has decreased by -42.21% in one year.
Market Cap
91.40B
Enterprise Value
101.72B
Revenue
91.42B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,380.00
Market Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 91.40B, a decrease of -50.27%. That is a compound annual growth rate of -11.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 91.40B | -35.54% |
| Dec 30, 2025 | 141.79B | -15.09% |
| Dec 30, 2024 | 166.98B | -35.26% |
| Dec 28, 2023 | 257.94B | 10.51% |
| Dec 29, 2022 | 233.40B | -55.92% |
| Dec 30, 2021 | 529.52B | 118.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ahn-Gook Pharmaceutical | 121.61B |
| DongKoo Bio & Pharma | 111.55B |
| HYUNDAI BIOLAND | 109.05B |
| OPTUS Pharmaceutical | 107.82B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 102.98B |
| H.PIO | 95.76B |
| Pharos iBio | 84.80B |
| Sam-A Pharm. | 84.29B |